You are here: Industry Insights > NAD+

News List

NAD+ Application in Pharmaceutical Industry and Regulatory Status in Multiple Countries and Markets Nurah Ekhlaque
April 25, 2025
This article highlights key applications, clinical trial developments, and regulatory classifications of NAD⁺ and its derivatives across major global markets.
Renue by Science Launches Innovative Liposomal NAD+ Skincare Line, Renue Blue, Emphasizing Skin Wellness and Longevity PRNewswire
January 08, 2025
Renue by Science™, a global leader in NAD+ precursor supplements, is excited to announce the official launch of its highly anticipated skincare range, Renue Blue™.
Penn Researchers Solve Decades Old Mitochondrial Mystery that Could Lead to New Disease Treatments University of Pennsylvania School of Medicine
September 24, 2020
Penn Medicine researchers have solved a decades old mystery around a key molecule fueling the power plant of cells that could be exploited to find new ways to treat diseases, from neurodegenerative disorders to cancer.